{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:29:02Z","timestamp":1789039742672,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA040314"],"award-info":[{"award-number":["UG1DA040314"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11606-024-09061-6","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T08:02:50Z","timestamp":1729756970000},"page":"1039-1047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence of Cannabis Use Disorder Among Primary Care Patients with Varying Frequency of Past-Year Cannabis Use"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6965-043X","authenticated-orcid":false,"given":"Gwen T.","family":"Lapham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer F.","family":"Bobb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Luce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malia M.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah K.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noorie","family":"Hyun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Hallgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa E.","family":"Matson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"9061_CR1","unstructured":"Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2020 National Survey on Drug Use and Health. Vol. HHS Publication No. PEP21\u201307\u201301\u2013003. 2021. https:\/\/www.samhsa.gov\/data\/. Accessed 14 February 2023."},{"key":"9061_CR2","unstructured":"National Conference of State Legislatures. State Medical Marijuana Laws. https:\/\/www.ncsl.org\/research\/health\/state-medical-marijuana-laws.aspx. Accessed 24 January 2024."},{"key":"9061_CR3","doi-asserted-by":"publisher","first-page":"102658","DOI":"10.1016\/j.drugpo.2019.102658","volume":"76","author":"S Goodman","year":"2020","unstructured":"Goodman S, Wadsworth E, Leos-Toro C, Hammond D. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets. Int J Drug Policy. 2020;76:102658. https:\/\/doi.org\/10.1016\/j.drugpo.2019.102658.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"9061_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1086\/721267","volume":"65","author":"A Hollingsworth","year":"2022","unstructured":"Hollingsworth A, Wing C, Bradford AC. Comparative effects of recreational and medical marijuana laws on drug use among adults and adolescents. J Law Econ. 2022;65(3):515-554. https:\/\/doi.org\/10.1086\/721267.","journal-title":"J Law Econ."},{"issue":"9","key":"9061_CR5","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1111\/jgs.17213","volume":"69","author":"BH Han","year":"2021","unstructured":"Han BH, Funk\u2010White M, Ko R, Al\u2010Rousan T, Palamar JJ. Decreasing perceived risk associated with regular cannabis use among older adults in the United States from 2015 to 2019. J Am Geriatr Soc. 2021;69(9):2591-2597.","journal-title":"J Am Geriatr Soc."},{"key":"9061_CR6","doi-asserted-by":"crossref","first-page":"107552","DOI":"10.1016\/j.addbeh.2022.107552","volume":"138","author":"J Mennis","year":"2023","unstructured":"Mennis J, McKeon TP, Stahler GJ. Recreational cannabis legalization alters associations among cannabis use, perception of risk, and cannabis use disorder treatment for adolescents and young adults. Addictive behaviors. 2023;138:107552.","journal-title":"Addict Behav"},{"key":"9061_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13011-021-00352-3","volume":"16","author":"K Gali","year":"2021","unstructured":"Gali K, Winter SJ, Ahuja NJ, Frank E, Prochaska JJ. Changes in cannabis use, exposure, and health perceptions following legalization of adult recreational cannabis use in California: a prospective observational study. Subst Abuse Treat Prev Policy. 2021;16:1-10.","journal-title":"Subst Abuse Treat Prev Policy."},{"issue":"1","key":"9061_CR8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/can.2016.0007","volume":"1","author":"M Sexton","year":"2016","unstructured":"Sexton M, Cuttler C, Finnell JS, Mischley LK. A cross-sectional survey of medical cannabis users: patterns of use and perceived efficacy. Cannabis Cannabinoid Res. 2016;1(1):131-138.","journal-title":"Cannabis Cannabinoid Res."},{"key":"9061_CR9","doi-asserted-by":"crossref","first-page":"103716","DOI":"10.1016\/j.drugpo.2022.103716","volume":"105","author":"D Hammond","year":"2022","unstructured":"Hammond D, Goodman S, Wadsworth E, et al. Trends in the use of cannabis products in Canada and the USA, 2018\u20132020: Findings from the International Cannabis Policy Study. Int J Drug Policy. 2022;105:103716.","journal-title":"Int J Drug Policy"},{"issue":"1","key":"9061_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00406-019-00983-5","volume":"269","author":"S Chandra","year":"2019","unstructured":"Chandra S, Radwan MM, Majumdar CG, Church JC, Freeman TP, ElSohly MA. New trends in cannabis potency in USA and Europe during the last decade (2008-2017). Eur Arch Psychiatry Clin Neurosci. 2019;269(1):5-15. https:\/\/doi.org\/10.1007\/s00406-019-00983-5.","journal-title":"Eur Arch Psychiatry Clin Neurosci."},{"issue":"3","key":"9061_CR11","doi-asserted-by":"crossref","first-page":"e0230167","DOI":"10.1371\/journal.pone.0230167","volume":"15","author":"MC Cash","year":"2020","unstructured":"Cash MC, Cunnane K, Fan C, Romero-Sandoval EA. Mapping cannabis potency in medical and recreational programs in the United States. PloS one. 2020;15(3):e0230167.","journal-title":"PloS one."},{"issue":"12","key":"9061_CR12","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/add.13886","volume":"112","author":"R Smart","year":"2017","unstructured":"Smart R, Caulkins JP, Kilmer B, Davenport S, Midgette G. Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state. Addiction. 2017;112(12):2167-2177.","journal-title":"Addiction."},{"key":"9061_CR13","doi-asserted-by":"crossref","first-page":"102658","DOI":"10.1016\/j.drugpo.2019.102658","volume":"76","author":"S Goodman","year":"2020","unstructured":"Goodman S, Wadsworth E, Leos-Toro C, Hammond D, team ICPS. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets. Int J Drug Policy. 2020;76:102658.","journal-title":"Int J Drug Policy"},{"issue":"5","key":"9061_CR14","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/add.15253","volume":"116","author":"TP Freeman","year":"2021","unstructured":"Freeman TP, Craft S, Wilson J, et al. Changes in delta\u20109\u2010tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta\u2010analysis. Addiction. 2021;116(5):1000-1010.","journal-title":"Addiction."},{"issue":"23","key":"9061_CR15","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMra1402309","volume":"370","author":"ND Volkow","year":"2014","unstructured":"Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. Review. N Engl J Med. Jun 5 2014;370(23):2219-27. https:\/\/doi.org\/10.1056\/NEJMra1402309.","journal-title":"N Engl J Med."},{"issue":"8","key":"9061_CR16","doi-asserted-by":"crossref","first-page":"e2328934","DOI":"10.1001\/jamanetworkopen.2023.28934","volume":"6","author":"GT Lapham","year":"2023","unstructured":"Lapham GT, Matson TE, Bobb JF, et al. Prevalence of cannabis use disorder and reasons for use among adults in a US state where recreational cannabis use is legal. JAMA Netw Open. 2023;6(8):e2328934-e2328934.","journal-title":"JAMA Netw Open."},{"issue":"22","key":"9061_CR17","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1001\/jama.2020.8020","volume":"323","author":"US Preventive Services Task Force","year":"2020","unstructured":"US Preventive Services Task Force. Screening for unhealthy drug use: US Preventive Services Task Force recommendation statement. JAMA. 2020;323(22):2301-2309. https:\/\/doi.org\/10.1001\/jama.2020.8020.","journal-title":"JAMA."},{"issue":"11","key":"9061_CR18","doi-asserted-by":"publisher","first-page":"e2239772","DOI":"10.1001\/jamanetworkopen.2022.39772","volume":"5","author":"TE Matson","year":"2022","unstructured":"Matson TE, Lapham GT, Bobb JF, et al. Validity of the Single-Item Screen\u2013Cannabis (SIS-C) for Cannabis Use Disorder Screening in Routine Care. JAMA Netw Open. 2022;5(11):e2239772-e2239772. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.39772.","journal-title":"JAMA Netw Open."},{"issue":"3","key":"9061_CR19","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1080\/08897077.2018.1544964","volume":"40","author":"GT Lapham","year":"2019","unstructured":"Lapham GT, Campbell CI, Yarborough BJH, et al. The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems. Subst Abus. 2019;40(3):268-277. https:\/\/doi.org\/10.1080\/08897077.2018.1544964.","journal-title":"Subst Abus."},{"key":"9061_CR20","unstructured":"Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2022 National Survey on Drug Use and Health. Vol. HHS Publication No. PEP21-07-01-003. 2022. https:\/\/www.samhsa.gov\/data\/report\/2022-nsduh-annual-national-report. Accessed 25 January 2024."},{"issue":"1","key":"9061_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13012-018-0795-9","volume":"13","author":"JE Glass","year":"2018","unstructured":"Glass JE, Bobb JF, Lee AK, et al. Study protocol: a cluster-randomized trial implementing Sustained Patient-centered Alcohol-related Care (SPARC trial). Implement Sci. 2018;13(1):108. https:\/\/doi.org\/10.1186\/s13012-018-0795-9.","journal-title":"Implement Sci."},{"issue":"4","key":"9061_CR22","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jamainternmed.2022.7083","volume":"183","author":"AK Lee","year":"2023","unstructured":"Lee AK, Bobb JF, Richards JE, et al. Integrating alcohol-related prevention and treatment into primary care: A cluster randomized implementation trial. JAMA Intern Med. 2023;183(4):319-328. https:\/\/doi.org\/10.1001\/jamainternmed.2022.7083.","journal-title":"JAMA Intern Med."},{"issue":"11","key":"9061_CR23","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1007\/s11606-018-4558-8","volume":"33","author":"GT Lapham","year":"2018","unstructured":"Lapham GT, Lee AK, Caldeiro RM, et al. Prevalence of behavioral health conditions across frequency of cannabis use among adult primary care patients in Washington State. J Gen Intern Med. 2018;33(11):1833-1835. https:\/\/doi.org\/10.1007\/s11606-018-4558-8.","journal-title":"J Gen Intern Med."},{"key":"9061_CR24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.drugpo.2017.11.008","volume":"52","author":"C Russell","year":"2018","unstructured":"Russell C, Rueda S, Room R, Tyndall M, Fischer B. Routes of administration for cannabis use - basic prevalence and related health outcomes: A scoping review and synthesis. Int J Drug Policy. 2018;52:87-96. https:\/\/doi.org\/10.1016\/j.drugpo.2017.11.008.","journal-title":"Int J Drug Policy."},{"key":"9061_CR25","doi-asserted-by":"crossref","first-page":"103381","DOI":"10.1016\/j.drugpo.2021.103381","volume":"99","author":"B Fischer","year":"2022","unstructured":"Fischer B, Robinson T, Bullen C, et al. Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update. Int J Drug Policy. 2022;99:103381.","journal-title":"Int J Drug Policy"},{"issue":"5","key":"9061_CR26","doi-asserted-by":"publisher","first-page":"e2211677","DOI":"10.1001\/jamanetworkopen.2022.11677","volume":"5","author":"GT Lapham","year":"2022","unstructured":"Lapham GT, Matson TE, Carrell DS, et al. Comparison of medical cannabis use reported on a confidential survey vs documented in the electronic health record among primary care patients. JAMA Netw Open. 2022;5(5):e2211677-e2211677. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.11677.","journal-title":"JAMA Netw Open."},{"issue":"3","key":"9061_CR27","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/0376-8716(96)01249-5","volume":"41","author":"WM Compton","year":"1996","unstructured":"Compton WM, Cottler LB, Dorsey KB, Spitznagel EL, Mager DE. Comparing assessments of DSM-IV substance dependence disorders using CIDI-SAM and SCAN. Drug Alcohol Depend. 1996;41(3):179-87. https:\/\/doi.org\/10.1016\/0376-8716(96)01249-5.","journal-title":"Drug Alcohol Depend."},{"issue":"8","key":"9061_CR28","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.2105\/AJPH.2016.303198","volume":"106","author":"Y Guo","year":"2016","unstructured":"Guo Y, Kopec JA, Cibere J, Li LC, Goldsmith CH. Population survey features and response rates: A randomized experiment. Am J Public Health. 2016;106(8):1422-6. https:\/\/doi.org\/10.2105\/AJPH.2016.303198.","journal-title":"Am J Public Health."},{"issue":"10","key":"9061_CR29","doi-asserted-by":"publisher","first-page":"690","DOI":"10.7326\/m16-0317","volume":"165","author":"J McNeely","year":"2016","unstructured":"McNeely J, Wu LT, Subramaniam G, et al. Performance of the tobacco, alcohol, prescription medication, and other substance use (TAPS) tool for substance use screening in primary care patients. Ann Intern Med. 2016;165(10):690-699. https:\/\/doi.org\/10.7326\/m16-0317.","journal-title":"Ann Intern Med."},{"key":"9061_CR30","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed.\u00a0Arlington, Virginia: American Psychiatric Publishing; 2013.","edition":"5"},{"issue":"1","key":"9061_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amepre.2015.05.027","volume":"50","author":"GL Schauer","year":"2016","unstructured":"Schauer GL, King BA, Bunnell RE, Promoff G, McAfee TA. Toking, vaping, and eating for health or fun: Marijuana use patterns in adults, U.S., 2014. Am J Prev Med. 2016;50(1):1-8. https:\/\/doi.org\/10.1016\/j.amepre.2015.05.027.","journal-title":"Am J Prev Med."},{"key":"9061_CR32","first-page":"633","volume":"47","author":"DGTD Horvitz","year":"1952","unstructured":"Horvitz DG TD. A generalization of sampling without replacement from a finite universe. J Am Stat Assoc. 1952;47:633-65.","journal-title":"J Am Stat Assoc."},{"key":"9061_CR33","volume-title":"Survey Sampling","author":"L Kish","year":"1965","unstructured":"Kish L. Survey Sampling.\u00a0New York, NY: John Wiley & Sons, Inc.; 1965."},{"issue":"3","key":"9061_CR34","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1177\/096228029600500302","volume":"5","author":"JM Brick","year":"1996","unstructured":"Brick JM, Kalton G. Handling missing data in survey research. Stat Methods Med Res. Sep 1996;5(3):215-38. https:\/\/doi.org\/10.1177\/096228029600500302.","journal-title":"Stat Methods Med Res."},{"issue":"1","key":"9061_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1093\/biostatistics\/kxh020","volume":"6","author":"A Basu","year":"2005","unstructured":"Basu A, Rathouz PJ. Estimating marginal and incremental effects on health outcomes using flexible link and variance function models. Biostatistics. 2005;6(1):93-109. https:\/\/doi.org\/10.1093\/biostatistics\/kxh020.","journal-title":"Biostatistics."},{"key":"9061_CR36","doi-asserted-by":"crossref","unstructured":"Glick HA, Doshi JA, Sonnad SS, Polsky D. Economic evaluation in clinical trials.\u00a0Oxford, UK: OUP Oxford; 2014.","DOI":"10.1093\/med\/9780199685028.001.0001"},{"key":"9061_CR37","volume-title":"Stata Statistical Software: Release 17","author":"StataCorp","year":"2021","unstructured":"StataCorp. Stata Statistical Software: Release 17. College Station: StataCorp LLC; 2021."},{"issue":"4","key":"9061_CR38","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jamapsychiatry.2015.3229","volume":"73","author":"C Blanco","year":"2016","unstructured":"Blanco C, Hasin DS, Wall MM, et al. Cannabis use and risk of psychiatric disorders: Prospective evidence from a US national longitudinal study. JAMA Psychiatry. 2016;73(4):388-95. https:\/\/doi.org\/10.1001\/jamapsychiatry.2015.3229.","journal-title":"JAMA Psychiatry."},{"key":"9061_CR39","doi-asserted-by":"publisher","first-page":"106329","DOI":"10.1016\/j.addbeh.2020.106329","volume":"105","author":"RL Gunn","year":"2020","unstructured":"Gunn RL, Aston ER, Sokolovsky AW, White HR, Jackson KM. Complex cannabis use patterns: Associations with cannabis consequences and cannabis use disorder symptomatology. Addict Behav. 2020;105:106329. https:\/\/doi.org\/10.1016\/j.addbeh.2020.106329.","journal-title":"Addict Behav."},{"key":"9061_CR40","doi-asserted-by":"crossref","first-page":"106620","DOI":"10.1016\/j.addbeh.2020.106620","volume":"112","author":"C Swan","year":"2021","unstructured":"Swan C, Ferro MA, Thompson K. Does how you use matter? The link between mode of use and cannabis-related risk. Addict Behav. 2021;112:106620.","journal-title":"Addict Behav."},{"issue":"5","key":"9061_CR41","doi-asserted-by":"publisher","first-page":"e2316283","DOI":"10.1001\/jamanetworkopen.2023.16283","volume":"6","author":"TE Matson","year":"2023","unstructured":"Matson TE, Hallgren KA, Lapham GT, et al. Psychometric performance of a substance use symptom checklist to help clinicians assess substance use disorder in primary care. JAMA Netw Open. 2023;6(5):e2316283-e2316283. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.16283.","journal-title":"JAMA Netw Open."},{"issue":"1","key":"9061_CR42","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12875-021-01559-w","volume":"22","author":"ST R\u00f8nne","year":"2021","unstructured":"R\u00f8nne ST, Rosenb\u00e6k F, Pedersen LB, et al. Physicians\u2019 experiences, attitudes, and beliefs towards medical cannabis: a systematic literature review. BMC Family Practice. 2021;22(1):212. https:\/\/doi.org\/10.1186\/s12875-021-01559-w.","journal-title":"BMC Family Practice."},{"key":"9061_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.addbeh.2017.03.007","volume":"72","author":"E Brooks","year":"2017","unstructured":"Brooks E, Gundersen DC, Flynn E, Brooks-Russell A, Bull S. The clinical implications of legalizing marijuana: Are physician and non-physician providers prepared? Addict Behav. 2017;72:1-7. https:\/\/doi.org\/10.1016\/j.addbeh.2017.03.007.","journal-title":"Addict Behav."},{"issue":"5","key":"9061_CR44","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/phar.1747","volume":"36","author":"BJ Sherman","year":"2016","unstructured":"Sherman BJ, McRae\u2010Clark AL. Treatment of cannabis use disorder: current science and future outlook. Pharmacotherapy J Hum Pharmacol Drug Ther. 2016;36(5):511-535.","journal-title":"Pharmacotherapy J Hum Pharmacol Drug Ther."},{"key":"9061_CR45","doi-asserted-by":"crossref","unstructured":"Gates PJ, Sabioni P, Copeland J, Le Foll B, Gowing L. Psychosocial interventions for cannabis use disorder.\u00a0Cochrane Database Syst Rev.\u00a02016;(5).","DOI":"10.1002\/14651858.CD005336.pub4"},{"issue":"1","key":"9061_CR46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12954-024-00929-8","volume":"21","author":"DD King","year":"2024","unstructured":"King DD, Gill CJ, Cadieux CS, Singh N. The role of stigma in cannabis use disclosure: an exploratory study. Harm Reduction J. 2024;21(1):21.","journal-title":"Harm Reduction J."},{"key":"9061_CR47","unstructured":"Washington State Department of Health. Tobacco and Cannabis Use Dashboard. 2022. https:\/\/doh.wa.gov\/data-and-statistical-reports\/washington-tracking-network-wtn\/tobacco-and-cannabis\/dashboard. Accessed 17 April 2024."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-09061-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-024-09061-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-024-09061-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T18:11:25Z","timestamp":1764267085000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-024-09061-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["9061"],"URL":"https:\/\/doi.org\/10.1007\/s11606-024-09061-6","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]},"assertion":[{"value":"3 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"A National Institute on Drug Abuse (NIDA)\u2013appointed data and safety monitoring board reviewed the design and conduct of the study. The funder had no role in the collection, management, analysis, and interpretation of the data, preparation of the manuscript, or the decision to submit the manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Role of the Funder\/Sponsor"}},{"value":"Drs Lapham, Matson, and Bobb report grants from the National Institute on Drug Abuse during the conduct of the study. No other disclosures were reported.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest:"}},{"value":"The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute on Drug Abuse Clinical Trials Network, the National Institute on Drug Abuse, Kaiser Permanente, or Permanente Medicine.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer:"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}